Sleep-Disordered Breathing: Imposing Challenges in Spinal Cord Injury
Poor sleep quality in patients with spinal cord injury contributes to adverse outcomes, including cardiovascular events and rehabilitation challenges.
Obstructive Sleep Apnea
Age, BMI Predict Obstructive Sleep Apnea Treatment Success
Among patients with obstructive sleep apnea, older age and reduced BMI are predictors of upper airway stimulation treatment response.
Solriamfetol Feasible for Sleep Apnea-Related Tiredness
Solriamfetol therapy, compared with placebo, results in improvements in wakefulness and sleepiness measures in patients with excessive sleepiness due to obstructive sleep apnea.
Montelukast With or Without Intranasal Steroids Evaluated for Pediatric OSA
A team of authors performed a systematic review of studies examining anti-inflammatory treatments for pediatric OSA through June 28, 2018 using PubMed/MEDLINE and 4 other databases.
Short Respiratory Event Duration Ups Mortality Risk in OSA
For individuals with obstructive sleep apnea, those with short respiratory event duration have an increased risk for mortality.
Hypoglossal Nerve Stimulation Improves Objective Alertness, Sleep in Obstructive Sleep Apnea
The investigators found a significant reduction in the mean preimplantation apnea-hypopnea index at 6 months after hypoglossal nerve stimulation.
Primary Care Can Effectively Manage Obstructive Sleep Apnea
Primary care management of obstructive sleep apnea is as effective and more cost-effective than in-laboratory diagnosis.
Serotonin Reuptake Inhibitors May Improve OSA in Depression With and Without Epilepsy
Research was conducted to identify an association between the use of serotonin reuptake inhibitors and obstructive sleep apnea in a population of individuals with depression with or without epilepsy.
Reduced Cortical Thickness ID’d in Obstructive Sleep Apnea
Female OSA patients had multiple regions of reduced cortical thickness in superior frontal lobe.
FDA Accepts NDA for Narcolepsy, OSA-Related Sleepiness Treatment
The FDA has accepted the New Drug Application for solriamfetol for the treatment of sleep disorders.
Next post in Sleep Disorders
